Advertisement
UK markets close in 2 hours 9 minutes

  • FTSE 100

    8,076.25
    +31.44 (+0.39%)
     

  • FTSE 250

    19,765.26
    -34.46 (-0.17%)
     

  • AIM

    755.04
    +0.17 (+0.02%)
     

  • GBP/EUR

    1.1641
    +0.0013 (+0.11%)
     

  • GBP/USD

    1.2451
    -0.0001 (-0.01%)
     

  • Bitcoin GBP

    53,097.36
    -9.57 (-0.02%)
     

  • CMC Crypto 200

    1,429.54
    +5.44 (+0.38%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • CRUDE OIL

    82.95
    -0.41 (-0.49%)
     

  • GOLD FUTURES

    2,337.20
    -4.90 (-0.21%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     

  • DAX

    18,145.17
    +7.52 (+0.04%)
     

  • CAC 40

    8,131.49
    +25.71 (+0.32%)
     
Money:

The five essential pieces of financial paperwork you must never lose

Mislaying key documents can cause real headaches, so it’s worth tracking down these most commonly-lost bits of paperwork

GSK launches $890mln placement in Aspen Pharmacare - source

Reuters - UK Focus

LONDON, March 12 (Reuters) - GlaxoSmithKline (Other OTC: GLAXF - news) has launched a $890 million share sale in South African drug company Aspen Pharmacare, a source familiar with the matter said on Thursday.

GSK said earlier on Thursday that it had launched the sale of around half its holding in the company. A price range of 365-385 rand per share has been set for the placement, representing a discount of 5.3-10.2 percent to the closing price.

The share sale is being run by Citi and UBS (NYSEArca: FBGX - news) . (Reporting By Freya Berry and Vikram Subhedar; editing by Pamela Barbaglia)